Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | ADH1B | P00325 | 2/20 | 0.40 |
| ▸ | ADH1C | P00326 | 2/20 | 0.40 |
| ▸ | ADH1A | P07327 | 2/20 | 0.40 |
| ▸ | ADH4 | P08319 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 11/20 | 0.38 |
| ▸ | MAOB | P27338 | 7/20 | 0.38 |
| ▸ | MAOA | P21397 | 4/20 | 0.38 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.38 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexylamine SCHEMBL8025766 | 0.92 | ALDH1A1 (0.71) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL14459899 | 0.92 | ALDH1A1 (0.71) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| Cyclohexylamine SCHEMBL3142573 | 0.92 | ALDH1A1 (0.71) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL16121130 | 0.89 | ALDH1A1 (0.67) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL19366623 | 0.88 | ALDH1A1 (0.44) | ALDH1A1HSD17B10KDM1AMAOBMAOA | |
| SCHEMBL20907336 | 0.88 | ALDH1A1 (0.44) | ALDH1A1HSD17B10KDM1AMAOBMAOA | |
| SCHEMBL933210 | 0.88 | ALDH1A1 (0.44) | ALDH1A1HSD17B10KDM1AMAOBMAOA | |
| SCHEMBL1459410 | 0.85 | ALDH1A1 (0.42) | ALDH1A1HSD17B10KDM1AMAOBMAOA | |
| SCHEMBL5909148 | 0.85 | ALDH1A1 (0.92) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL613478 | 0.85 | ALDH1A1 (0.92) | ALDH1A1HSD17B10ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3623398-B1 | RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER | ASAHI CHEMICAL IND (JP) | 2024-08-28 | — | — | EP | disclosed |
| CN-110603273-B | Modified block copolymer, method for producing modified block copolymer, and resin composition | 旭化成株式会社 | 2022-10-14 | — | — | CN | disclosed |
| US-11124593-B2 | Modified block copolymer, method for producing modified block copolymer, and resin composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-09-21 | — | — | US | disclosed |
| US-20200199282-A1 | Modified Block Copolymer, Method for Producing Modified Block Copolymer, and Resin Composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-3623398-A1 | MODIFIED BLOCK COPOLYMER, METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER, AND RESIN COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2020-03-18 | — | — | EP | disclosed |
| CN-110603273-A | Modified block copolymer, method for producing modified block copolymer, and resin composition | 旭化成株式会社 | 2019-12-20 | — | — | CN | disclosed |
| US-9926259-B1 | Catalyst for fixed bed aniline rectification residue recycling and preparation method | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2018-03-27 | — | — | US | disclosed |
| US-20180065916-A1 | CATALYST FOR FIXED BED ANILINE RECTIFICATION RESIDUE RECYCLING AND PREPARATION METHOD | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2018-03-08 | — | — | US | disclosed |
| EP-2444397-A1 | Heteroaryl-ureas and their use as glucokinase activators | Novo Nordisk A/S (DK) | 2012-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065916-A1 | CATALYST FOR FIXED BED ANILINE RECTIFICATION RESIDUE RECYCLING AND PREPARATION METHOD | SCO2, KMO, JMJD6 | ALDH1A1 2142/4885HSD17B10 2792/4885ADH1B 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.